Preclinical studies on new proteins as carrier for glycoconjugate vaccines
Abstract Glycoconjugate vaccines are made of carbohydrate antigens covalently bound to a carrier protein to enhance their immunogenicity. Among the different carrier proteins tested in preclinical and clinical studies, five have been used so far for licensed vaccines: Diphtheria and Tetanus toxoids,...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2016-07, Vol.34 (35), p.4235-4242 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 4242 |
|---|---|
| container_issue | 35 |
| container_start_page | 4235 |
| container_title | Vaccine |
| container_volume | 34 |
| creator | Tontini, M Romano, M.R Proietti, D Balducci, E Micoli, F Balocchi, C Santini, L Masignani, V Berti, F Costantino, P |
| description | Abstract Glycoconjugate vaccines are made of carbohydrate antigens covalently bound to a carrier protein to enhance their immunogenicity. Among the different carrier proteins tested in preclinical and clinical studies, five have been used so far for licensed vaccines: Diphtheria and Tetanus toxoids, the non-toxic mutant of diphtheria toxin CRM197 , the outer membrane protein complex of Neisseria meningitidis serogroup B and the Protein D derived from non-typeable Haemophilus influenzae . Availability of novel carriers might help to overcome immune interference in multi-valent vaccines containing several polysaccharide-conjugate antigens, and also to develop vaccines which target both protein as well saccharide epitopes of the same pathogen. Accordingly we have conducted a study to identify new potential carrier proteins. Twenty-eight proteins, derived from different bacteria, were conjugated to the model polysaccharide Laminarin and tested in mice for their ability in inducing antibodies against the carbohydrate antigen and eight of them were subsequently tested as carrier for serogroup meningococcal C oligosaccharides. Four out of these eight were able to elicit in mice satisfactory anti meningococcal serogroup C titers. Based on immunological evaluation, the Streptococcus pneumoniae protein spr96/2021 was successfully evaluated as carrier for serogroups A, C, W, Y and X meningococcal capsular saccharides. |
| doi_str_mv | 10.1016/j.vaccine.2016.06.039 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808645288</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X16304637</els_id><sourcerecordid>4120676831</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-ddf49201e7672c1f638c2d39a6f5860aa55c486cc27607daace76ef585e64c53</originalsourceid><addsrcrecordid>eNqFkV1rFTEQhoMo9rT6E5SAN97sMd-bvVFK0aoUFOyFdyHOzpase5Ka7FbOvzfLOVXojTAQwjwz8847hLzgbMsZN2_G7Z0HCBG3on63rIbsHpENt61shOb2MdkwYVSjOPt-Qk5LGRljWvLuKTkRreSt0npDPn_NCFOIAfxEy7z0AQtNkUb8TW9zmjHEQn2h4HMOmOmQMr2Z9pAgxXG58TPSo47yjDwZ_FTw-fE9I9cf3l9ffGyuvlx-uji_akALOzd9P6iuasbWtAL4YKQF0cvOm0Fbw7zXGpQ1AKI1rO29h0pizWk0CrQ8I68Pbau8XwuW2e1CAZwmHzEtxXHLrFF1lK3oqwfomJYcq7iV0spwyUSl9IGCnErJOLjbHHY-7x1nbvXaje64o1u9dqyG7Grdy2P35ccO-79V9-ZW4N0BwOrGXXXPFQgYAftQTZ9dn8J_R7x90OH-Vj9xj-XfNq4Ix9y39eDrvbmRTBnZyj-BGqcf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1805461302</pqid></control><display><type>article</type><title>Preclinical studies on new proteins as carrier for glycoconjugate vaccines</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tontini, M ; Romano, M.R ; Proietti, D ; Balducci, E ; Micoli, F ; Balocchi, C ; Santini, L ; Masignani, V ; Berti, F ; Costantino, P</creator><creatorcontrib>Tontini, M ; Romano, M.R ; Proietti, D ; Balducci, E ; Micoli, F ; Balocchi, C ; Santini, L ; Masignani, V ; Berti, F ; Costantino, P</creatorcontrib><description>Abstract Glycoconjugate vaccines are made of carbohydrate antigens covalently bound to a carrier protein to enhance their immunogenicity. Among the different carrier proteins tested in preclinical and clinical studies, five have been used so far for licensed vaccines: Diphtheria and Tetanus toxoids, the non-toxic mutant of diphtheria toxin CRM197 , the outer membrane protein complex of Neisseria meningitidis serogroup B and the Protein D derived from non-typeable Haemophilus influenzae . Availability of novel carriers might help to overcome immune interference in multi-valent vaccines containing several polysaccharide-conjugate antigens, and also to develop vaccines which target both protein as well saccharide epitopes of the same pathogen. Accordingly we have conducted a study to identify new potential carrier proteins. Twenty-eight proteins, derived from different bacteria, were conjugated to the model polysaccharide Laminarin and tested in mice for their ability in inducing antibodies against the carbohydrate antigen and eight of them were subsequently tested as carrier for serogroup meningococcal C oligosaccharides. Four out of these eight were able to elicit in mice satisfactory anti meningococcal serogroup C titers. Based on immunological evaluation, the Streptococcus pneumoniae protein spr96/2021 was successfully evaluated as carrier for serogroups A, C, W, Y and X meningococcal capsular saccharides.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2016.06.039</identifier><identifier>PMID: 27317455</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Allergy and Immunology ; Animals ; Antibodies, Bacterial - blood ; Antibody Formation ; Antigens ; Candidates ; Carrier protein ; Carrier Proteins - chemistry ; Chromatography ; CRM197 ; Diphtheria ; E coli ; Genomes ; Glucans - chemistry ; Glycoconjugates ; Glycoconjugates - chemistry ; Haemophilus influenzae ; Immunogenicity ; Immunogenicity, Vaccine ; Licenses ; Manufacturing ; Meningococcal vaccines ; Mens health ; Mice ; Mice, Inbred BALB C ; Neisseria meningitidis ; Neisseria meningitidis, Serogroup C ; Polysaccharides, Bacterial - immunology ; Proteins ; Recombinant Proteins - chemistry ; Research centers ; Saccharides ; Serum Bactericidal Antibody Assay ; Streptococcus infections ; Streptococcus pneumoniae ; Tetanus ; Toxins ; Vaccines ; Vaccines, Conjugate - chemistry ; Vaccines, Conjugate - immunology</subject><ispartof>Vaccine, 2016-07, Vol.34 (35), p.4235-4242</ispartof><rights>2016</rights><rights>Copyright © 2016. Published by Elsevier Ltd.</rights><rights>Copyright Elsevier Limited Jul 29, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-ddf49201e7672c1f638c2d39a6f5860aa55c486cc27607daace76ef585e64c53</citedby><cites>FETCH-LOGICAL-c528t-ddf49201e7672c1f638c2d39a6f5860aa55c486cc27607daace76ef585e64c53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X16304637$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27317455$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tontini, M</creatorcontrib><creatorcontrib>Romano, M.R</creatorcontrib><creatorcontrib>Proietti, D</creatorcontrib><creatorcontrib>Balducci, E</creatorcontrib><creatorcontrib>Micoli, F</creatorcontrib><creatorcontrib>Balocchi, C</creatorcontrib><creatorcontrib>Santini, L</creatorcontrib><creatorcontrib>Masignani, V</creatorcontrib><creatorcontrib>Berti, F</creatorcontrib><creatorcontrib>Costantino, P</creatorcontrib><title>Preclinical studies on new proteins as carrier for glycoconjugate vaccines</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract Glycoconjugate vaccines are made of carbohydrate antigens covalently bound to a carrier protein to enhance their immunogenicity. Among the different carrier proteins tested in preclinical and clinical studies, five have been used so far for licensed vaccines: Diphtheria and Tetanus toxoids, the non-toxic mutant of diphtheria toxin CRM197 , the outer membrane protein complex of Neisseria meningitidis serogroup B and the Protein D derived from non-typeable Haemophilus influenzae . Availability of novel carriers might help to overcome immune interference in multi-valent vaccines containing several polysaccharide-conjugate antigens, and also to develop vaccines which target both protein as well saccharide epitopes of the same pathogen. Accordingly we have conducted a study to identify new potential carrier proteins. Twenty-eight proteins, derived from different bacteria, were conjugated to the model polysaccharide Laminarin and tested in mice for their ability in inducing antibodies against the carbohydrate antigen and eight of them were subsequently tested as carrier for serogroup meningococcal C oligosaccharides. Four out of these eight were able to elicit in mice satisfactory anti meningococcal serogroup C titers. Based on immunological evaluation, the Streptococcus pneumoniae protein spr96/2021 was successfully evaluated as carrier for serogroups A, C, W, Y and X meningococcal capsular saccharides.</description><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antibody Formation</subject><subject>Antigens</subject><subject>Candidates</subject><subject>Carrier protein</subject><subject>Carrier Proteins - chemistry</subject><subject>Chromatography</subject><subject>CRM197</subject><subject>Diphtheria</subject><subject>E coli</subject><subject>Genomes</subject><subject>Glucans - chemistry</subject><subject>Glycoconjugates</subject><subject>Glycoconjugates - chemistry</subject><subject>Haemophilus influenzae</subject><subject>Immunogenicity</subject><subject>Immunogenicity, Vaccine</subject><subject>Licenses</subject><subject>Manufacturing</subject><subject>Meningococcal vaccines</subject><subject>Mens health</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neisseria meningitidis</subject><subject>Neisseria meningitidis, Serogroup C</subject><subject>Polysaccharides, Bacterial - immunology</subject><subject>Proteins</subject><subject>Recombinant Proteins - chemistry</subject><subject>Research centers</subject><subject>Saccharides</subject><subject>Serum Bactericidal Antibody Assay</subject><subject>Streptococcus infections</subject><subject>Streptococcus pneumoniae</subject><subject>Tetanus</subject><subject>Toxins</subject><subject>Vaccines</subject><subject>Vaccines, Conjugate - chemistry</subject><subject>Vaccines, Conjugate - immunology</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkV1rFTEQhoMo9rT6E5SAN97sMd-bvVFK0aoUFOyFdyHOzpase5Ka7FbOvzfLOVXojTAQwjwz8847hLzgbMsZN2_G7Z0HCBG3on63rIbsHpENt61shOb2MdkwYVSjOPt-Qk5LGRljWvLuKTkRreSt0npDPn_NCFOIAfxEy7z0AQtNkUb8TW9zmjHEQn2h4HMOmOmQMr2Z9pAgxXG58TPSo47yjDwZ_FTw-fE9I9cf3l9ffGyuvlx-uji_akALOzd9P6iuasbWtAL4YKQF0cvOm0Fbw7zXGpQ1AKI1rO29h0pizWk0CrQ8I68Pbau8XwuW2e1CAZwmHzEtxXHLrFF1lK3oqwfomJYcq7iV0spwyUSl9IGCnErJOLjbHHY-7x1nbvXaje64o1u9dqyG7Grdy2P35ccO-79V9-ZW4N0BwOrGXXXPFQgYAftQTZ9dn8J_R7x90OH-Vj9xj-XfNq4Ix9y39eDrvbmRTBnZyj-BGqcf</recordid><startdate>20160729</startdate><enddate>20160729</enddate><creator>Tontini, M</creator><creator>Romano, M.R</creator><creator>Proietti, D</creator><creator>Balducci, E</creator><creator>Micoli, F</creator><creator>Balocchi, C</creator><creator>Santini, L</creator><creator>Masignani, V</creator><creator>Berti, F</creator><creator>Costantino, P</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7U2</scope></search><sort><creationdate>20160729</creationdate><title>Preclinical studies on new proteins as carrier for glycoconjugate vaccines</title><author>Tontini, M ; Romano, M.R ; Proietti, D ; Balducci, E ; Micoli, F ; Balocchi, C ; Santini, L ; Masignani, V ; Berti, F ; Costantino, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-ddf49201e7672c1f638c2d39a6f5860aa55c486cc27607daace76ef585e64c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antibody Formation</topic><topic>Antigens</topic><topic>Candidates</topic><topic>Carrier protein</topic><topic>Carrier Proteins - chemistry</topic><topic>Chromatography</topic><topic>CRM197</topic><topic>Diphtheria</topic><topic>E coli</topic><topic>Genomes</topic><topic>Glucans - chemistry</topic><topic>Glycoconjugates</topic><topic>Glycoconjugates - chemistry</topic><topic>Haemophilus influenzae</topic><topic>Immunogenicity</topic><topic>Immunogenicity, Vaccine</topic><topic>Licenses</topic><topic>Manufacturing</topic><topic>Meningococcal vaccines</topic><topic>Mens health</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neisseria meningitidis</topic><topic>Neisseria meningitidis, Serogroup C</topic><topic>Polysaccharides, Bacterial - immunology</topic><topic>Proteins</topic><topic>Recombinant Proteins - chemistry</topic><topic>Research centers</topic><topic>Saccharides</topic><topic>Serum Bactericidal Antibody Assay</topic><topic>Streptococcus infections</topic><topic>Streptococcus pneumoniae</topic><topic>Tetanus</topic><topic>Toxins</topic><topic>Vaccines</topic><topic>Vaccines, Conjugate - chemistry</topic><topic>Vaccines, Conjugate - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tontini, M</creatorcontrib><creatorcontrib>Romano, M.R</creatorcontrib><creatorcontrib>Proietti, D</creatorcontrib><creatorcontrib>Balducci, E</creatorcontrib><creatorcontrib>Micoli, F</creatorcontrib><creatorcontrib>Balocchi, C</creatorcontrib><creatorcontrib>Santini, L</creatorcontrib><creatorcontrib>Masignani, V</creatorcontrib><creatorcontrib>Berti, F</creatorcontrib><creatorcontrib>Costantino, P</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Safety Science and Risk</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tontini, M</au><au>Romano, M.R</au><au>Proietti, D</au><au>Balducci, E</au><au>Micoli, F</au><au>Balocchi, C</au><au>Santini, L</au><au>Masignani, V</au><au>Berti, F</au><au>Costantino, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preclinical studies on new proteins as carrier for glycoconjugate vaccines</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2016-07-29</date><risdate>2016</risdate><volume>34</volume><issue>35</issue><spage>4235</spage><epage>4242</epage><pages>4235-4242</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Abstract Glycoconjugate vaccines are made of carbohydrate antigens covalently bound to a carrier protein to enhance their immunogenicity. Among the different carrier proteins tested in preclinical and clinical studies, five have been used so far for licensed vaccines: Diphtheria and Tetanus toxoids, the non-toxic mutant of diphtheria toxin CRM197 , the outer membrane protein complex of Neisseria meningitidis serogroup B and the Protein D derived from non-typeable Haemophilus influenzae . Availability of novel carriers might help to overcome immune interference in multi-valent vaccines containing several polysaccharide-conjugate antigens, and also to develop vaccines which target both protein as well saccharide epitopes of the same pathogen. Accordingly we have conducted a study to identify new potential carrier proteins. Twenty-eight proteins, derived from different bacteria, were conjugated to the model polysaccharide Laminarin and tested in mice for their ability in inducing antibodies against the carbohydrate antigen and eight of them were subsequently tested as carrier for serogroup meningococcal C oligosaccharides. Four out of these eight were able to elicit in mice satisfactory anti meningococcal serogroup C titers. Based on immunological evaluation, the Streptococcus pneumoniae protein spr96/2021 was successfully evaluated as carrier for serogroups A, C, W, Y and X meningococcal capsular saccharides.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>27317455</pmid><doi>10.1016/j.vaccine.2016.06.039</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2016-07, Vol.34 (35), p.4235-4242 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1808645288 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Allergy and Immunology Animals Antibodies, Bacterial - blood Antibody Formation Antigens Candidates Carrier protein Carrier Proteins - chemistry Chromatography CRM197 Diphtheria E coli Genomes Glucans - chemistry Glycoconjugates Glycoconjugates - chemistry Haemophilus influenzae Immunogenicity Immunogenicity, Vaccine Licenses Manufacturing Meningococcal vaccines Mens health Mice Mice, Inbred BALB C Neisseria meningitidis Neisseria meningitidis, Serogroup C Polysaccharides, Bacterial - immunology Proteins Recombinant Proteins - chemistry Research centers Saccharides Serum Bactericidal Antibody Assay Streptococcus infections Streptococcus pneumoniae Tetanus Toxins Vaccines Vaccines, Conjugate - chemistry Vaccines, Conjugate - immunology |
| title | Preclinical studies on new proteins as carrier for glycoconjugate vaccines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T21%3A35%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preclinical%20studies%20on%20new%20proteins%20as%20carrier%20for%20glycoconjugate%20vaccines&rft.jtitle=Vaccine&rft.au=Tontini,%20M&rft.date=2016-07-29&rft.volume=34&rft.issue=35&rft.spage=4235&rft.epage=4242&rft.pages=4235-4242&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2016.06.039&rft_dat=%3Cproquest_cross%3E4120676831%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1805461302&rft_id=info:pmid/27317455&rft_els_id=S0264410X16304637&rfr_iscdi=true |